n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia

Jackie Bosch; Hertzel C Gerstein; Gilles R Dagenais; Rafael Díaz; Leanne Dyal; Hyejung Jung; Aldo P Maggiono; Jeffrey Probstfield; Ambady Ramachandran; Matthew C Riddle; Lars E Rydén; Salim Yusuf; ORIGIN Trial Investigators; Thure Krarup; Hans Jørgen Duckert Perrild; Christian Tobias Torp-Pedersen

doi:10.1056/NEJMoa1203859

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia

Jackie Bosch, Hertzel C Gerstein, Gilles R Dagenais, Rafael Díaz, Leanne Dyal, Hyejung Jung, Aldo P Maggiono, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle, Lars E Rydén, Salim Yusuf, ORIGIN Trial Investigators, Thure Krarup, Hans Jørgen Duckert Perrild, Christian Tobias Torp-Pedersen

Research output: Contribution to journal › Journal article › Research › peer-review

777 Citations (Scopus)

Abstract

The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown.

Original language	English
Journal	New England Journal of Medicine
Volume	367
Issue number	4
Pages (from-to)	309-18
Number of pages	10
ISSN	0028-4793
DOIs	https://doi.org/10.1056/NEJMoa1203859
Publication status	Published - 2012

Access to Document

10.1056/NEJMoa1203859

Cite this

Bosch, J., Gerstein, H. C., Dagenais, G. R., Díaz, R., Dyal, L., Jung, H., Maggiono, A. P., Probstfield, J., Ramachandran, A., Riddle, M. C., Rydén, L. E., Yusuf, S., ORIGIN Trial Investigators, Krarup, T., Perrild, H. J. D., & Torp-Pedersen, C. T. (2012). n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. New England Journal of Medicine, 367(4), 309-18. https://doi.org/10.1056/NEJMoa1203859

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. / Bosch, Jackie; Gerstein, Hertzel C; Dagenais, Gilles R; Díaz, Rafael; Dyal, Leanne; Jung, Hyejung; Maggiono, Aldo P; Probstfield, Jeffrey; Ramachandran, Ambady; Riddle, Matthew C; Rydén, Lars E; Yusuf, Salim; ORIGIN Trial Investigators; Krarup, Thure; Perrild, Hans Jørgen Duckert ; Torp-Pedersen, Christian Tobias.

In: New England Journal of Medicine, Vol. 367, No. 4, 2012, p. 309-18.

Research output: Contribution to journal › Journal article › Research › peer-review

Bosch, J, Gerstein, HC, Dagenais, GR, Díaz, R, Dyal, L, Jung, H, Maggiono, AP, Probstfield, J, Ramachandran, A, Riddle, MC, Rydén, LE, Yusuf, S, ORIGIN Trial Investigators, Krarup, T, Perrild, HJD & Torp-Pedersen, CT 2012, 'n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia', New England Journal of Medicine, vol. 367, no. 4, pp. 309-18. https://doi.org/10.1056/NEJMoa1203859

Bosch, Jackie ; Gerstein, Hertzel C ; Dagenais, Gilles R ; Díaz, Rafael ; Dyal, Leanne ; Jung, Hyejung ; Maggiono, Aldo P ; Probstfield, Jeffrey ; Ramachandran, Ambady ; Riddle, Matthew C ; Rydén, Lars E ; Yusuf, Salim ; ORIGIN Trial Investigators ; Krarup, Thure ; Perrild, Hans Jørgen Duckert ; Torp-Pedersen, Christian Tobias. / n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. In: New England Journal of Medicine. 2012 ; Vol. 367, No. 4. pp. 309-18.

@article{c80f0dbfdd1c4b0f93cdd6a5db1177ae,

title = "n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia",

abstract = "The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown.",

author = "Jackie Bosch and Gerstein, {Hertzel C} and Dagenais, {Gilles R} and Rafael D{\'i}az and Leanne Dyal and Hyejung Jung and Maggiono, {Aldo P} and Jeffrey Probstfield and Ambady Ramachandran and Riddle, {Matthew C} and Ryd{\'e}n, {Lars E} and Salim Yusuf and Torp-Pedersen, {Christian Tobias} and Thure Krarup and Perrild, {Hans J{\o}rgen Duckert} and Torp-Pedersen, {Christian Tobias}",

year = "2012",

doi = "10.1056/NEJMoa1203859",

language = "English",

volume = "367",

pages = "309--18",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "4",

}

TY - JOUR

T1 - n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia

AU - Bosch, Jackie

AU - Gerstein, Hertzel C

AU - Dagenais, Gilles R

AU - Díaz, Rafael

AU - Dyal, Leanne

AU - Jung, Hyejung

AU - Maggiono, Aldo P

AU - Probstfield, Jeffrey

AU - Ramachandran, Ambady

AU - Riddle, Matthew C

AU - Rydén, Lars E

AU - Yusuf, Salim

AU - ORIGIN Trial Investigators

AU - Krarup, Thure

AU - Perrild, Hans Jørgen Duckert

AU - Torp-Pedersen, Christian Tobias

PY - 2012

Y1 - 2012

N2 - The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown.

AB - The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown.

U2 - 10.1056/NEJMoa1203859

DO - 10.1056/NEJMoa1203859

M3 - Journal article

C2 - 22686415

VL - 367

SP - 309

EP - 318

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 4

ER -